JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263330

Human RNF149 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

RNF149 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.

View Alternative Names

DNA polymerase-transactivated protein 2, DNAPTP2, E3 ubiquitin-protein ligase RNF149, RING finger protein 149, RN149_HUMAN, Rnf149

2 Images
Sanger Sequencing - Human RNF149 knockout HeLa cell lysate (AB263330)
  • Sanger seq

Unknown

Sanger Sequencing - Human RNF149 knockout HeLa cell lysate (AB263330)

Allele-2 : Insertion of the selection cassette in exon1

Sanger Sequencing - Human RNF149 knockout HeLa cell lysate (AB263330)
  • Sanger seq

Unknown

Sanger Sequencing - Human RNF149 knockout HeLa cell lysate (AB263330)

Allele-1 : 1 bp deletion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263330-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RNF149 knockout HeLa cell lysate", "number":"AB263330-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263330-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
RNF149
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RNF149 also known as RING Finger Protein 149 is an E3 ubiquitin-protein ligase which means it catalyzes the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate protein tagging it for degradation. The mass of RNF149 is approximately 49 kDa. It can be found expressed in various tissues with notable presence in the liver and kidney. This protein contains a RING-type zinc finger domain which is critical for its ligase activity and substrate specificity.
Biological function summary

RNF149 participates in protein quality control by mediating the ubiquitination of proteins that require degradation therefore maintaining protein homeostasis. It acts independently and is not part of a larger protein complex. By tagging damaged or misfolded proteins for degradation RNF149 contributes to the cellular stress response ensuring that cells respond to potential stressors effectively and efficiently.

Pathways

The involvement of RNF149 in the ubiquitin-proteasome system places it within the protein degradation pathway which is essential for regulating protein turnover and cellular function. It interacts with several other proteins including ubiquitin-conjugating enzyme E2s in this pathway. RNF149 may also intersect with apoptosis pathways due to its role in controlling the degradation of apoptotic regulators linking it to proteins involved in cell death processes.

RNF149 shows a connection to certain cancers and neurodegenerative diseases. Abnormal expression or mutations in RNF149 can relate to the deregulation of protein turnover contributing to the development of hepatocellular carcinoma. It is also connected to neurodegenerative disorders due to its role in degrading damaged proteins with connections to proteins like p53 in cancer pathways and tau proteins in neurological contexts.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com